Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy.

Current treatment options in infectious diseases

Osiowy C, Coffin C, Andonov A.
PMID: 27547127
Curr Treat Options Infect Dis. 2016;8:177-193. doi: 10.1007/s40506-016-0080-x. Epub 2016 Jul 02.

There are only two currently approved classes of hepatitis B virus (HBV) antiviral agents, pegylated interferon (Peg-IFN), and nucleos(t)ide analogs (NAs) for chronic HBV infection. Although Peg-IFN is used for a finite 48-week duration and offers a greater chance...

Cite
Osiowy C, Coffin C, Andonov A. Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Curr Treat Options Infect Dis. 2016;8:177-193doi: 10.1007/s40506-016-0080-x.
Osiowy, C., Coffin, C., & Andonov, A. (2016). Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Current treatment options in infectious diseases, 8177-193. https://doi.org/10.1007/s40506-016-0080-x
Osiowy, Carla, et al. "Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy." Current treatment options in infectious diseases vol. 8 (2016): 177-193. doi: https://doi.org/10.1007/s40506-016-0080-x
Osiowy C, Coffin C, Andonov A. Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Curr Treat Options Infect Dis. 2016;8:177-193. doi: 10.1007/s40506-016-0080-x. Epub 2016 Jul 02. PMID: 27547127; PMCID: PMC4969325.
Copy Download .nbib Format: NLM
Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up.

PloS one

Virine B, Osiowy C, Gao S, Wang T, Castillo E, Martin SR, Lee SS, Simmonds K, van Marle G, Coffin CS.
PMID: 26690969
PLoS One. 2015 Dec 21;10(12):e0145898. doi: 10.1371/journal.pone.0145898. eCollection 2015.

No abstract available.

Cite
Virine B, Osiowy C, Gao S, et al. Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up. PLoS One. 2015;10(12):e0145898doi: 10.1371/journal.pone.0145898.
Virine, B., Osiowy, C., Gao, S., Wang, T., Castillo, E., Martin, S. R., Lee, S. S., Simmonds, K., van Marle, G., & Coffin, C. S. (2015). Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up. PloS one, 10(12), e0145898. https://doi.org/10.1371/journal.pone.0145898
Virine, Boris, et al. "Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up." PloS one vol. 10,12 (2015): e0145898. doi: https://doi.org/10.1371/journal.pone.0145898
Virine B, Osiowy C, Gao S, Wang T, Castillo E, Martin SR, Lee SS, Simmonds K, van Marle G, Coffin CS. Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up. PLoS One. 2015 Dec 21;10(12):e0145898. doi: 10.1371/journal.pone.0145898. eCollection 2015. PMID: 26690969; PMCID: PMC4686842.
Copy Download .nbib Format: NLM
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.

Viruses

Vachon A, Osiowy C.
PMID: 34064049
Viruses. 2021 May 21;13(6). doi: 10.3390/v13060951.

Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used, over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require monitoring of treatment response, viral activity, and disease progression to...

Cite
Vachon A, Osiowy C. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses. 2021;13(6)doi: 10.3390/v13060951.
Vachon, A., & Osiowy, C. (2021). Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses, 13(6), . https://doi.org/10.3390/v13060951
Vachon, Alicia, and Osiowy, Carla. "Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management." Viruses vol. 13,6 (2021). doi: https://doi.org/10.3390/v13060951
Vachon A, Osiowy C. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses. 2021 May 21;13(6). doi: 10.3390/v13060951. PMID: 34064049; PMCID: PMC8224022.
Copy Download .nbib Format: NLM
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.

Viruses

Vachon A, Osiowy C.
PMID: 34064049
Viruses. 2021 May 21;13(6). doi: 10.3390/v13060951.

Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used, over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require monitoring of treatment response, viral activity, and disease progression to...

Cite
Vachon A, Osiowy C. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses. 2021;13(6)doi: 10.3390/v13060951.
Vachon, A., & Osiowy, C. (2021). Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses, 13(6), . https://doi.org/10.3390/v13060951
Vachon, Alicia, and Osiowy, Carla. "Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management." Viruses vol. 13,6 (2021). doi: https://doi.org/10.3390/v13060951
Vachon A, Osiowy C. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses. 2021 May 21;13(6). doi: 10.3390/v13060951. PMID: 34064049; PMCID: PMC8224022.
Copy Download .nbib Format: NLM
Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison.

PloS one

Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, Galipeau Y, Langlois MA, Gingras AC, Yansouni CP, Papenburg J, Cheng MP, Chakraborty P, Stein DR, Van Caeseele P, Bartlett S, Krajden M, Goldfarb D, McGeer A, Osiowy C, Hankins C, Mazer B, Drebot M, Kim J.
PMID: 34874948
PLoS One. 2021 Dec 07;16(12):e0261003. doi: 10.1371/journal.pone.0261003. eCollection 2021.

The true severity of infection due to COVID-19 is under-represented because it is based on only those who are tested. Although nucleic acid amplifications tests (NAAT) are the gold standard for COVID-19 diagnostic testing, serological assays provide better population-level...

Cite
Cholette F, Mesa C, Harris A, et al. Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison. PLoS One. 2021;16(12):e0261003doi: 10.1371/journal.pone.0261003.
Cholette, F., Mesa, C., Harris, A., Ellis, H., Cachero, K., Lacap, P., Galipeau, Y., Langlois, M. A., Gingras, A. C., Yansouni, C. P., Papenburg, J., Cheng, M. P., Chakraborty, P., Stein, D. R., Van Caeseele, P., Bartlett, S., Krajden, M., Goldfarb, D., McGeer, A., Osiowy, C., Hankins, C., Mazer, B., Drebot, M., Kim, J. (2021). Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison. PloS one, 16(12), e0261003. https://doi.org/10.1371/journal.pone.0261003
Cholette, François, et al. "Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison." PloS one vol. 16,12 (2021): e0261003. doi: https://doi.org/10.1371/journal.pone.0261003
Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, Galipeau Y, Langlois MA, Gingras AC, Yansouni CP, Papenburg J, Cheng MP, Chakraborty P, Stein DR, Van Caeseele P, Bartlett S, Krajden M, Goldfarb D, McGeer A, Osiowy C, Hankins C, Mazer B, Drebot M, Kim J. Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison. PLoS One. 2021 Dec 07;16(12):e0261003. doi: 10.1371/journal.pone.0261003. eCollection 2021. PMID: 34874948; PMCID: PMC8651133.
Copy Download .nbib Format: NLM
Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Willmore J, Ellis E, Etches V, Labrecque L, Osiowy C, Andonov A, McDermaid C, Majury A, Achonu C, Maher M, MacLean B, Levy I.
PMID: 26015789
Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):77-84. doi: 10.1155/2015/160536.

OBJECTIVE: To determine whether transmission of blood-borne pathogens (BBPs) (hepatitis B virus [HBV], hepatitis C virus [HCV] and HIV) occurred as a result of endoscopy reprocessing failures identified during an inspection of a nonhospital endoscopy clinic in 2011.METHODS: The...

Cite
Willmore J, Ellis E, Etches V, et al. Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic. Can J Infect Dis Med Microbiol. 2015;26(2):77-84doi: 10.1155/2015/160536.
Willmore, J., Ellis, E., Etches, V., Labrecque, L., Osiowy, C., Andonov, A., McDermaid, C., Majury, A., Achonu, C., Maher, M., MacLean, B., & Levy, I. (2015). Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 26(2), 77-84. https://doi.org/10.1155/2015/160536
Willmore, Jacqueline, et al. "Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 26,2 (2015): 77-84. doi: https://doi.org/10.1155/2015/160536
Willmore J, Ellis E, Etches V, Labrecque L, Osiowy C, Andonov A, McDermaid C, Majury A, Achonu C, Maher M, MacLean B, Levy I. Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic. Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):77-84. doi: 10.1155/2015/160536. PMID: 26015789; PMCID: PMC4419818.
Copy Download .nbib Format: NLM
Editorial: Origin and Evolution of Hepatitis Viruses.

Frontiers in microbiology

Osiowy C, Yuen L.
PMID: 34512616
Front Microbiol. 2021 Aug 25;12:740255. doi: 10.3389/fmicb.2021.740255. eCollection 2021.

No abstract available.

Cite
Osiowy C, Yuen L. Editorial: Origin and Evolution of Hepatitis Viruses. Front Microbiol. 2021;12:740255doi: 10.3389/fmicb.2021.740255.
Osiowy, C., & Yuen, L. (2021). Editorial: Origin and Evolution of Hepatitis Viruses. Frontiers in microbiology, 12740255. https://doi.org/10.3389/fmicb.2021.740255
Osiowy, Carla, and Yuen, Lilly. "Editorial: Origin and Evolution of Hepatitis Viruses." Frontiers in microbiology vol. 12 (2021): 740255. doi: https://doi.org/10.3389/fmicb.2021.740255
Osiowy C, Yuen L. Editorial: Origin and Evolution of Hepatitis Viruses. Front Microbiol. 2021 Aug 25;12:740255. doi: 10.3389/fmicb.2021.740255. eCollection 2021. PMID: 34512616; PMCID: PMC8424193.
Copy Download .nbib Format: NLM
Social Capital and Autism in Young Adulthood: Applying Social Network Methods to Measure the Social Capital of Autistic Young Adults.

Autism in adulthood : challenges and management

McGhee Hassrick E, Sosnowy C, Graham Holmes L, Walton J, Shattuck PT.
PMID: 32954220
Autism Adulthood. 2020 Sep 01;2(3):243-254. doi: 10.1089/aut.2019.0058. Epub 2020 Sep 03.

Social isolation is a core challenge associated with autism. Interpersonal relationships and the resources and support embedded in the social networks of autistic young adults could impact key adult outcomes, including quality of life, mental health, employment, and independence....

Cite
McGhee Hassrick E, Sosnowy C, Graham Holmes L, et al. Social Capital and Autism in Young Adulthood: Applying Social Network Methods to Measure the Social Capital of Autistic Young Adults. Autism Adulthood. 2020;2(3):243-254doi: 10.1089/aut.2019.0058.
McGhee Hassrick, E., Sosnowy, C., Graham Holmes, L., Walton, J., & Shattuck, P. T. (2020). Social Capital and Autism in Young Adulthood: Applying Social Network Methods to Measure the Social Capital of Autistic Young Adults. Autism in adulthood : challenges and management, 2(3), 243-254. https://doi.org/10.1089/aut.2019.0058
McGhee Hassrick, Elizabeth, et al. "Social Capital and Autism in Young Adulthood: Applying Social Network Methods to Measure the Social Capital of Autistic Young Adults." Autism in adulthood : challenges and management vol. 2,3 (2020): 243-254. doi: https://doi.org/10.1089/aut.2019.0058
McGhee Hassrick E, Sosnowy C, Graham Holmes L, Walton J, Shattuck PT. Social Capital and Autism in Young Adulthood: Applying Social Network Methods to Measure the Social Capital of Autistic Young Adults. Autism Adulthood. 2020 Sep 01;2(3):243-254. doi: 10.1089/aut.2019.0058. Epub 2020 Sep 03. PMID: 32954220; PMCID: PMC7497874.
Copy Download .nbib Format: NLM
Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype.

Frontiers in microbiology

de Bernardi Schneider A, Osiowy C, Hostager R, Krarup H, Børresen M, Tanaka Y, Morriseau T, Wertheim JO.
PMID: 33519744
Front Microbiol. 2021 Jan 15;11:602296. doi: 10.3389/fmicb.2020.602296. eCollection 2020.

A disproportionate number of Greenland's Inuit population are chronically infected with Hepatitis B virus (HBV; 5-10%). HBV genotypes B and D are most prevalent in the circumpolar Arctic. Here, we report 39 novel HBV/D sequences from individuals residing in...

Cite
de Bernardi Schneider A, Osiowy C, Hostager R, et al. Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype. Front Microbiol. 2021;11:602296doi: 10.3389/fmicb.2020.602296.
de Bernardi Schneider, A., Osiowy, C., Hostager, R., Krarup, H., Børresen, M., Tanaka, Y., Morriseau, T., & Wertheim, J. O. (2020). Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype. Frontiers in microbiology, 11602296. https://doi.org/10.3389/fmicb.2020.602296
de Bernardi Schneider, Adriano, et al. "Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype." Frontiers in microbiology vol. 11 (2020): 602296. doi: https://doi.org/10.3389/fmicb.2020.602296
de Bernardi Schneider A, Osiowy C, Hostager R, Krarup H, Børresen M, Tanaka Y, Morriseau T, Wertheim JO. Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype. Front Microbiol. 2021 Jan 15;11:602296. doi: 10.3389/fmicb.2020.602296. eCollection 2020. PMID: 33519744; PMCID: PMC7843931.
Copy Download .nbib Format: NLM
Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling.

PeerJ

Bouckaert R, Simons BC, Krarup H, Friesen TM, Osiowy C.
PMID: 28875087
PeerJ. 2017 Aug 31;5:e3757. doi: 10.7717/peerj.3757. eCollection 2017.

BACKGROUND: Indigenous populations of the circumpolar Arctic are considered to be endemically infected (>2% prevalence) with hepatitis B virus (HBV), with subgenotype B5 (formerly B6) unique to these populations. The distinctive properties of HBV/B5, including high nucleotide diversity yet...

Cite
Bouckaert R, Simons BC, Krarup H, et al. Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling. PeerJ. 2017;5:e3757doi: 10.7717/peerj.3757.
Bouckaert, R., Simons, B. C., Krarup, H., Friesen, T. M., & Osiowy, C. (2017). Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling. PeerJ, 5e3757. https://doi.org/10.7717/peerj.3757
Bouckaert, Remco, et al. "Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling." PeerJ vol. 5 (2017): e3757. doi: https://doi.org/10.7717/peerj.3757
Bouckaert R, Simons BC, Krarup H, Friesen TM, Osiowy C. Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling. PeerJ. 2017 Aug 31;5:e3757. doi: 10.7717/peerj.3757. eCollection 2017. PMID: 28875087; PMCID: PMC5581946.
Copy Download .nbib Format: NLM
Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells.

Journal of clinical and experimental hepatology

Bautista WW, Osiowy C, Klein J, Minuk GY.
PMID: 30765937
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):34-42. doi: 10.1016/j.jceh.2018.02.002. Epub 2018 Feb 16.

BACKGROUND/AIMS: Whether the hepatitis B virus (HBV) infects normal hepatic stem/progenitor cells (NSCs) and if so, whether such infections play a role in the pathogenesis of HBV-induced chronic liver disease (CLD) and/or hepatocellular carcinoma (HCC) remains to be determined....

Cite
Bautista WW, Osiowy C, Klein J, et al. Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells. J Clin Exp Hepatol. 2018;9(1):34-42doi: 10.1016/j.jceh.2018.02.002.
Bautista, W. W., Osiowy, C., Klein, J., & Minuk, G. Y. (2019). Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells. Journal of clinical and experimental hepatology, 9(1), 34-42. https://doi.org/10.1016/j.jceh.2018.02.002
Bautista, Wendy W, et al. "Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells." Journal of clinical and experimental hepatology vol. 9,1 (2019): 34-42. doi: https://doi.org/10.1016/j.jceh.2018.02.002
Bautista WW, Osiowy C, Klein J, Minuk GY. Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):34-42. doi: 10.1016/j.jceh.2018.02.002. Epub 2018 Feb 16. PMID: 30765937; PMCID: PMC6363946.
Copy Download .nbib Format: NLM
Effect of Processing on Postprandial Glycemic Response and Consumer Acceptability of Lentil-Containing Food Items.

Foods (Basel, Switzerland)

Ramdath DD, Wolever TMS, Siow YC, Ryland D, Hawke A, Taylor C, Zahradka P, Aliani M.
PMID: 29751679
Foods. 2018 May 11;7(5). doi: 10.3390/foods7050076.

The consumption of pulses is associated with many health benefits. This study assessed post-prandial blood glucose response (PPBG) and the acceptability of food items containing green lentils. In human trials we: (i) defined processing methods (boiling, pureeing, freezing, roasting,...

Cite
Ramdath DD, Wolever TMS, Siow YC, et al. Effect of Processing on Postprandial Glycemic Response and Consumer Acceptability of Lentil-Containing Food Items. Foods. 2018;7(5)doi: 10.3390/foods7050076.
Ramdath, D. D., Wolever, T. M. S., Siow, Y. C., Ryland, D., Hawke, A., Taylor, C., Zahradka, P., & Aliani, M. (2018). Effect of Processing on Postprandial Glycemic Response and Consumer Acceptability of Lentil-Containing Food Items. Foods (Basel, Switzerland), 7(5), . https://doi.org/10.3390/foods7050076
Ramdath, D Dan, et al. "Effect of Processing on Postprandial Glycemic Response and Consumer Acceptability of Lentil-Containing Food Items." Foods (Basel, Switzerland) vol. 7,5 (2018). doi: https://doi.org/10.3390/foods7050076
Ramdath DD, Wolever TMS, Siow YC, Ryland D, Hawke A, Taylor C, Zahradka P, Aliani M. Effect of Processing on Postprandial Glycemic Response and Consumer Acceptability of Lentil-Containing Food Items. Foods. 2018 May 11;7(5). doi: 10.3390/foods7050076. PMID: 29751679; PMCID: PMC5977096.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries